BMP5 and Parkinson disease: Moreover, both GDF5 [49] and BMP5/BMP7 [50] have recently been shown to protect against α-synuclein-induced dopaminergic degeneration in rat and mouse models of PD, and GDF5 is known to induce NME1 expression in vitro and in vivo [21].